Mustang Bio Inc [NASDAQ: MBIO] stock went on an upward path that rose over 476.92% on Monday, amounting to a one-week price increase of more than 453.10%.
Over the last 12 months, MBIO stock dropped by -89.74%. The one-year Mustang Bio Inc stock forecast points to a potential upside of 92.5. The average equity rating for MBIO stock is currently 1.00, trading closer to a bullish pattern in the stock market.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for the stock reached $21.18 million, with 28.24 million shares outstanding and 22.50 million shares in the current float. Compared to the average trading volume of 3.22M shares, MBIO stock reached a trading volume of 1113367370 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Mustang Bio Inc [MBIO]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MBIO shares is $10.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MBIO stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
BTIG Research have made an estimate for Mustang Bio Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on May 18, 2021. While these analysts kept the previous recommendation, B. Riley FBR raised their target price to Buy. The new note on the price target was released on October 02, 2020, representing the official price target for Mustang Bio Inc stock. Previously, the target price had yet another raise to $7, while Cantor Fitzgerald analysts kept a Overweight rating on MBIO stock.
MBIO Stock Performance Analysis:
Mustang Bio Inc [MBIO] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 453.10. With this latest performance, MBIO shares gained by 149.92% in over the last four-week period, additionally sinking by -47.55% over the last 6 months – not to mention a drop of -89.74% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MBIO stock in for the last two-week period is set at 80.69, with the RSI for the last a single of trading hit 88.59, and the three-weeks RSI is set at 72.07 for Mustang Bio Inc [MBIO]. The present Moving Average for the last 50 days of trading for this stock 0.3020, while it was recorded at 0.2624 for the last single week of trading, and 1.2518 for the last 200 days.
Insight into Mustang Bio Inc Fundamentals:
Mustang Bio Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.53 and a Current Ratio set at 0.53.
Mustang Bio Inc [MBIO] Institutonal Ownership Details
The top three institutional holders of MBIO stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.4983%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $200.69 billion in MBIO stocks shares; and BERKSHIRE HATHAWAY INC, currently with $174.35 billion in MBIO stock with ownership which is approximately 5.8386%.
